Announcements Trials

Browse Landscape

Phase

Status

Completed 6 Active not recruiting 5 Terminated 2 Recruiting 2 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 27 Head & Neck 3 Gastrointestinal 3 Dermatologic 3 Tumor-Agnostic 2 Thoracic 2 Genitourinary 2 Sarcoma 1 Other hematologic neoplasm 1 Lymphoid 1 Gynecologic 1 CNS 1

Conditions

Sarcoma 1 Osteosarcoma 1 Chordoma 1

Interventions

Doxorubicin 25 Radiotherapy 16 apatinib 15 Cyclophosphamide 15 Ifosfamide 13 anlotinib 12 camrelizumab 10 Temozolomide 9 Imatinib Mesylate 9 Vincristine 8 Surgical Procedures, Operative 7 Neoadjuvant Therapy 7 Methotrexate 7 Drug Therapy 7 Dactinomycin 5 Blood Specimen Collection 5 fludarabine phosphate 4 Paclitaxel 4 Immune Checkpoint Inhibitors 4 Etoposide 4 Docetaxel 4 Carboplatin 4 toripalimab 3 pembrolizumab 3 Trabectedin 3 Topotecan 3 Surveys and Questionnaires 3 Radiation Dose Hypofractionation 3 Nivolumab 3 Melphalan 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × palbociclib × Sarcoma × Clear all

NCT03242382 2024-01-23

PalboSarc

Grupo Espanol de Investigacion en Sarcomas

Phase 2 Unknown

Chordoma, Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡